Seattle, WA -- (SBWIRE) -- 11/14/2019 -- Intravenous solutions (IV) are administered through the intravenous route in order to provide sugar, salt, and water directly into veins. IV solutions and electrolytes are used for fluid resuscitation, routine maintenance, replacement, and redistribution. Intravenous drugs, nutrition, and mixed solutions are modern therapy. The growth of this market is expected to grow on the account of the rising adoption of inorganic growth strategies such as collaborations and acquisitions by key players in order to expand their portfolio. For instance, in April 2015, Baxter International Inc. and France-based Laboratoire Aguettant SAS entered into a licensing and distribution agreement for trace elements, which are essential micronutrients used in parenteral nutrition (PN) therapy.
The global intravenous solution market size was valued at US$ 8,372.0 million in 2019 and is expected to witness a CAGR of 6.1% over the forecast period (2019 – 2027).
Download A Readymade Sample PDF Copy: https://www.coherentmarketinsights.com/insight/request-sample/1134
Rising Launches and Regulatory Approvals for Intravenous Solution Injection is projected to Drive Growth of the Global Intravenous Solution Market
Rising approvals for intravenous solution injections from regulatory authorities are projected to drive the global intravenous solution market growth over the forecast period. For instance, in 2015, B. Braun Medical Inc, a subsidiary of B.Braun, operating in infusion therapy and pain management, announced the U.S. FDA approval for its 70% Dextrose for Injection in a 2L flexible container. 70% Dextrose for Injection is an intravenous solution indicated as a source of calories and fluid replenishment.
Moreover, launches of new intravenous solution injections for the treatment of various chronic diseases such as dehydration, gastrointestinal diseases are projected to drive the intravenous solution market growth over the forecast period. For instance, in 2017, Fresenius Kabi USA, LLC, offers medicines and technologies for infusion, transfusion, and clinical nutrition launched of Vecuronium Bromide for Injection in the U.S. The drug is indicated for maintenance of neuromuscular blockade and paralysis.
Intravenous Solution Market - Restraints
Increasing FDA recalls of IV products is the major factor hampering market growth. For instance, in August 2018, the U.S. FDA recalled Becton Dickinson & Company's NEXIVA Closed IV Catheter System Dual Port 18GA 1.25 IN (BD Nexiva catheter) due to failure in the needle tip shield/safety mechanism.
Get PDF Brochure of This Business Report: https://www.coherentmarketinsights.com/insight/request-pdf/1134
Intravenous Solution Market- Regional Insights
Based on the region, the global intravenous solution market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Europe is expected to hold a dominant position in the global intravenous solution market over the forecast period, and this can be attributed to increasing introduction of parenteral (intravenous) nutrition (PN) products. For instance, in 2016, Baxter International Inc., a global leader in PN therapy, launched NUMETA G13E 300 mL in Europe. NUMETA G13E is the only ready-to-use parenteral (intravenous) nutrition (PN) product for preterm infants (less than 37 weeks gestation age).
At the same time, Asia Pacific is expected to experience a rapid growth in the intravenous solution market, owing to the rising introduction of technologically advanced intravenous solutions by key players. For instance, in June 2019, Eurolife Healthcare, a manufacturer and distributor of specialty infusion & pharmaceuticals, launched two intravenous IV products: Discport and Lifeport in the India drug market. The product is considered a smart intravenous infusion, which encompasses the latest technology that reduces the chances of any infection.
Intravenous Solution Market - Competitive Landscape
Key players operating in the global intravenous solution market include Baxter International Inc, ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited.
Get Customized Report as per your Need: https://www.coherentmarketinsights.com/insight/request-customization/1134
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.